We've Rebranded!

HT-ADME is now NE-ADME (New Era of ADME & Beyond) Conference

Thursday, June 16th, 2022

In-Person Event - Novartis Institutes for BioMedical Research, Cambridge, MA

NE-ADME event will be an in-person meeting. However, remote attendance option will also be made available just in case you are still not able to travel.

Plenary Speakers for 2022

 

Brooke M. Rock, PhD

Director, Department of Pharmacokinetics & Drug Metabolism @ Amgen Inc.

GalNAc Targeted Liver Delivery of siRNAs and Small Molecules/Bispecific Ab's

  

Roger D. Kamm, PhD

Cecil and Ida Green Distinguished Professor of Biological and Mechanical Engineering @ MIT

Vascular and Lymphatic Barrier Function in the Brain and Subcutaneous Compartments

           

Speakers Confirmed for 2022

 

Mailys De Sousa Mendes, PhD

Senior Research Scientist @ Certara UK

Mechanistic Modeling of Caco-2 Experiments to Estimate Intrinsic Permeability

  

Li Di, PhD

Research Fellow @ Pfizer, Inc.

Prediction Accuracy of Volume of Distribution Using In Vitro, In Vivo, PBPK and QSAR Methods

 

Charles Knutson, PhD

Associate Director @ Novartis Institutes for BioMedical Research

Panel Discussion

 

James Kozloski, PhD

Principal Research Scientist @ IBM

Populations of Models for Virtual Patient/Cohort Construction in ADME/PK

 

Ryan Pelis, PhD

Senior Investigator I @ Novartis Institutes for BioMedical Research

Tools Toward Predicting Oral Lymphatic Absorption

 

Haojing Rong, PhD

Vice President of Preclinical Development @ Kymera Therapeutics

The Knowns and Unknowns of ADME/PK of Targeted Protein Degraders

   

Yuanxin Xu, PhD

Sr. VP of Early Development and Translational Medicine @ Intellia Therapeutics, Inc.

Of Mice and Man: Path to Clinical CRISPR/Cas9 Genome Editing Therapeutic Development

 

    

Doug Burdette, PhD

Director of DMPK and Clinical Pharmacology @ Moderna Therapeutics, Inc.

Title TBA

   

Dipen Vyas, PhD

Study Director (ADME-Tox) @ BioIVT

Long-term HEPATOPAC® Cultures: Model Validation for ADME-Tox Applications

 

Panel Discussion:

Expedited Drug Discovery Post-COVID 

 Participants:

Brooke Rock, Amgen

Doug Burdette & Lei Ci, Moderna

Charlie Knutson, Novartis

SESSION I: Advances in ADME of New Modalities

SESSION II: Novel In Silico Tools for ADME in Drug Discovery

SESSION III: Contributions of Vascular and Lymphatic Compartments to Drug Absorption

SESSION IV: ADME of COVID Therapeutics and Beyond

Workshops

Session I: Advances in ADME of New Modalities

Session II: Novel in silico Tools for ADME in Drug Discovery

Session III: Drug Delivery to Unusual Targets

Session IV: ADME of COVID Therapeutics and Beyond

 

Registration

Click here to register for the NE-ADME conference online.

NE-ADME 2022 will take place June 16, 2022

Novartis, Cambridge, MA

 

The Boston Society

The Boston Society (R) is an internationally-recognized NON-PROFIT organization dedicated to bringing the best scientific ideas to industrial practice through focused, timely workshops and conferences. 501(c)3

Updates

Sign Up Today!

Privacy Policy